LALPATHLABHealthcare Service Provider
Dr Lal PathLabs Ltd — PE Ratio & Valuation Analysis
₹1312.10
-0.17%
Current P/E47.83xPrice to earnings
Industry P/E39.28xSector average
4Y Avg P/E59.8x20.1% below avg
⚠️
21.8% Premium to Industry
LALPATHLAB P/E 47.83x vs sector avg 39.28x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹58.40 | ₹1483 | 25.4x |
| 2024 | ₹42.98 | ₹3000 | 69.8x |
| 2023 | ₹28.74 | ₹2578 | 89.7x |
| 2022 | ₹41.57 | ₹2260 | 54.4x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Dr Lal PathLabs Ltd Valuation
Dr Lal PathLabs Ltd (LALPATHLAB) currently trades at 47.83x earnings. The Healthcare Service Provider sector average PE is 39.28x. LALPATHLAB commands a premium, reflecting high growth expectations. Historically, LALPATHLAB has traded at an average PE of 59.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
24.30%
Dividend Yield
0.79%
More on Dr Lal PathLabs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.